GLP-1 drugs also seem to have anti-addictive properties some users report that they have fewer cravings for alcohol or have become less likely to engage in other addictive behaviors, such as gambling, shopping, or nail-biting
Key takeaways include: Obesity drug coverage in Medicaid remains limited, with 13 state Medicaid programs covering GLP-1s for obesity treatment under fee-for-service (FFS) as of January 2026
The bottom line: peptide therapy for MS shows genuine scientific promise
Its used by everyone from professional athletes recovering from torn tendons to patients managing chronic gut inflammation
Endocrinology (1986) 119(4):146775
Addition of LINA to EMPA enhances USE via reduction of ENaC expression, reduces UAE, and inhibits kidney injury in deoxycorticosterone acetate/salt (DS)-administered, uninephrectomized mice DS-administered, uninephrectomized mice (DS mice) have been known to exhibit glomerular hyperfiltration and severe kidney injury with ENaC activation 24